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Cristina Almeida-Aguiar3 and Fátima Baltazar1,2*Abstract
Background: Propolis is a resin collected by bees from plant buds and exudates, which is further processed
through the activity of bee enzymes. Propolis has been shown to possess many biological and pharmacological
properties, such as antimicrobial, antioxidant, immunostimulant and antitumor activities. Due to this bioactivity
profile, this resin can become an alternative, economic and safe source of natural bioactive compounds.
Antitumor action has been reported in vitro and in vivo for propolis extracts or its isolated compounds; however,
Portuguese propolis has been little explored. The aim of this work was to evaluate the in vitro antitumor activity of
Portuguese propolis on the human colon carcinoma cell line HCT-15, assessing the effect of different fractions
(hexane, chloroform and ethanol residual) of a propolis ethanol extract on cell viability, proliferation, metabolism
and death.
Methods: Propolis from Angra do Heroísmo (Azores) was extracted with ethanol and sequentially fractionated in
solvents with increasing polarity, n-hexane and chloroform. To assess cell viability, cell proliferation and cell death,
Sulforhodamine B, BrDU incorporation assay and Anexin V/Propidium iodide were used, respectively. Glycolytic
metabolism was estimated using specific kits.
Results: All propolis samples exhibited a cytotoxic effect against tumor cells, in a dose- and time-dependent way.
Chloroform fraction, the most enriched in phenolic compounds, appears to be the most active, both in terms of
inhibition of viability and cell death. Data also show that this cytotoxicity involves disturbance in tumor cell
glycolytic metabolism, seen by a decrease in glucose consumption and lactate production.
Conclusion: Our results show that Portuguese propolis from Angra do Heroísmo (Azores) can be a potential
therapeutic agent against human colorectal cancer.
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Propolis is a resin containing a complex mixture of com-
pounds that honeybees collect from several plants, further
digest with salivary enzymes and mix with beeswax. Prop-
olis is composed mainly by wax and resin, but also con-
tains essential oils, pollen, phenolic acids or their esters,
flavonoids, terpenes, aromatic aldehydes, alcohols, and
fatty acids, among others [1]. Propolis composition de-
pends on various factors such as the source of plant spe-
cies from which propolis is made and on environmental* Correspondence: fbaltazar@ecsaude.uminho.pt
1Life and Health Sciences Research Institute (ICVS), School of Health Sciences,
University of Minho, Braga, Portugal
2ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portugal
Full list of author information is available at the end of the article
© 2013 Valença et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfactors, which constitute a difficulty to its standardization
[2,3]. For instance, Brazilian propolis is composed essen-
tially by prenylated p-coumaric acids and diterpenic acids
[4], whereas propolis of temperate zones is mainly com-
posed by flavones, flavanones, cinnamic acids and their es-
ters [2,5]. Although scarcely studied, Portuguese propolis
appears to be composed by the typical phenolic acids and
flavonoids found in samples of temperate zones, especially
in Europe, but it contains also several other new com-
pounds that had never been referred before [6].
Propolis has been extensively employed in folk medi-
cine since ancient times. Recently, a wide range of
biological and pharmacological actions have been demon-
strated for several types of propolis, such as antibacteriall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[11,12], antioxidant [13,14], hepatoprotective [15], immu-
nostimulant [16] and antitumor activities [13,17-19],
among others.
Portuguese propolis pharmacological properties have
been little explored. In fact, this resin has been highly
neglected by both beekeepers and the scientific commu-
nity. Only its chemical composition [6,20], antioxidant
activity [13,20,21] and antitumor activity on renal cell
carcinoma [13] have been studied on a few samples of
some regions of Portugal. These few studies revealed di-
versity in terms of chemical composition and biological
properties, as well as the presence of some compounds
never found in propolis from other origins [6], renewing
the interest in studying this natural compound.
Thus, the aim of this work was to assess and
characterize the antitumor activity of a propolis sample
collected in Angra do Heroísmo (Archipelago of Azores,
Portugal) in a colon cancer cell line, including its effects
on tumour cell glycolytic metabolism. Despite evidence
that some compounds occasionally present in propolis
are able to inhibit lactate transport [22-26], to the best
of our knowledge, propolis potential in disturbing can-
cer cell metabolism was never investigated.Table 1 Total polyphenol and flavonoid contents ofMethods
Preparation of propolis extracts and fractions
Propolis was collected in March 2009 from Apis
mellifera beehives located in Angra do Heroísmo (AH),
Azores, Portugal. Propolis (40 g) was frozen at −18°C,
grounded and extracted at room temperature with etha-
nol under slow stirring. The obtained solution was
filtered and re-extracted twice more under the same
conditions, giving the ethanol extract (EE) after filtration
and solvent evaporation. This sample was designated
AH.EE.09. The extract was further and sequentially
fractionated in solvents with increasing polarity - n-
hexane (H) and chloroform (C) – yielding, after solvent
removal at 40°C under vacuum, the hexane (AH.FH.09)
and the chloroform fractions (AH.FC.09) of propolis
and a residual ethanol extract fraction (AH.FEr.09).
Dried fractions were stored at 4°C and were diluted in
DMSO to obtain the working solutions at the desired
concentrations.propolis were determined in all the fractions of Angra do
Heroísmo propolis
Total polyphenols (mg/ml) Total flavonoids (mg/ml)
AH. FH.09a) 134.3 ± 1.3 13.5 ± 0.4
AH.FC.09b) 214.8 ± 9.1 25.5 ± 0.6
AH.FEr.09c) 194.0 ± 4.7 26.9 ± 0.4
Each value indicates mean ± SD.
a) Hexane fraction.
b) Chloroform fraction.
c) Ethanol residual fraction.Determination of total polyphenol and flavonoid contents
Total phenolic content was determined according to the
Folin–Ciocalteu colorimetric method [27], with some
modifications, and using gallic acid as standard.
Total flavonoid content was quantified according to
the method described by Woisky and Salatino [28], with
some modifications. Quercetin was used as standard for
total flavonoid content quantification.Cell culture
The experiments were performed on the human colo-
rectal adenocarcinoma cell line HCT-15. Cells were
grown in RPMI 1640 medium (Gibco, Invitrogen,
USA) supplemented with 10% fetal bovine serum
(Gibco, Invitrogen, USA) and 1% penicillin/strepto-
mycin (Invitrogen, USA). Cells were incubated at 37°C
in atmosphere containing 5% CO2.
Cell viability assay
Cell viability was measured by the sulforhodamine B
assay (Sigma Chemical Company, MO, USA) following
the manufacturer’s instructions. HCT-15 cells were incu-
bated in 96-well plates (1×104 cells/well) with different
concentrations (0.005 mg/ml – 0.05 mg/ml) of propolis
samples for 24, 48 and 72 hours. Controls were treated
with DMSO alone (1%).
Results are presented as mean ± SD of three independ-
ent experiments, each in triplicate. IC50 values were cal-
culated for each propolis fraction and time point.
Cell proliferation assay
Cell proliferation was measured using the 5-bromo-2′-
deoxyuridine (BrdU) Cell Proliferation Assay (Roche,
Mannheim, Germany). HCT-15 cells were incubated in
96-well plates (1×104 cells/well) for 24 hours with the
half maximal inhibitory concentrations (IC50s) and two
higher concentrations (0.025 and 0.05 mg/ml) of AH.
FC.09 and AH.FEr.09. Controls were treated with DMSO
alone (1%). BrdU was added after 24 hours of propolis
exposure and was quantified according to the manufac-
turer’s instructions using a microplate reader (Model
680, Bio Rad) at 450 nm.
Results are presented as mean ± SD of three independ-
ent experiments, each in triplicate.
Cell metabolism assay
Extracellular glucose and lactate were measured
using commercial kits for glucose (Cobas, Roche)
and lactate (Spinreact, S.A.U.) according to the ma-
nufacturer’s protocols, but scaled down to microplate
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Figure 1 Effect of propolis on HCT-15 cell viability. HCT-15 cells were treated for 24, 48 and 72 h with different concentrations of propolis
fractions - AH.FH.09 (a), AH.FC.09 (b) and AH.FEr.09 (c) - and control cells were treated with DMSO alone. Results are expressed as percentage of
cell biomass.
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in 24-well plates (4×105 cells/well) with the IC50
concentrations for AH.FC.09 and AH.FEr.09, at
24 hours, and two higher concentrations (see above).
Controls were treated with DMSO alone (1%).
Results are presented as mean ± SD of three independ-
ent experiments, each in triplicate.Table 2 IC50 values of propolis fractions - AH.FH.09, AH.
FC.09 and AH.FEr.09 - on HCT-15 cell line
AH.FH.09a)(mg/ml) AH.FC.09b)(mg/ml) AH.FEr.09c)(mg/ml)
24 h 0.020 0.01 0.015
48 h 0.024 0.007 0.009
72 h 0.026 0.005 0.005
a) Hexane fraction of Angra do Heroísmo propolis collected in 2009.
b) Chloroform fraction of Angra do Heroísmo propolis collected in 2009.
c) Ethanol residual fraction of Angra do Heroísmo propolis collected in 2009.Cell death assay
Apoptotic and necrotic cell populations were deter-
mined by Annexin V (BD Biosciences). Briefly, HCT-
15 cells were seeded in T25 flasks and incubated
until 90% confluence. Cells were treated with AH.
FC.09 and AH.FEr.09 at IC50 concentrations for
24 hours. Controls were treated with DMSO alone
(1%). After incubation, culture supernatant was re-
covered from each flask and treated cells were
trypsinized. Cell pellets were ressuspended in 1 ml
binding buffer (10 mM Hepes pH 7.4, 140 mM NaCl
and 2.5 mM CaCl2) and centrifuged at 2000 rpm ×
5 min. Then, cells were incubated 15 min. with stain-
ing solution (8 μl Annexin and 30 μl PI (50 μg/ml)
per 100 μl of binding buffer) at room temperature.
The percentage of cell death was assessed by flow cy-
tometry (LSRII model, BD Biosciences): a total of
20,000 events was recovered and the results were an-
alyzed using the FlowJo software (version 7.6; Tree
Star, Inc.).Results are presented as mean ± SD of three independ-
ent experiments.Statistical analysis
Statistic analysis was performed using the GraphPad
Prism. Unpaired t-test was performed to compare two
groups. Significance was considered as p < 0.05.Results
Propolis polyphenol and flavonoid contents
The values for total polyphenol and flavonoid contents
(Table 1) show that AH.FC.09 has the greatest amount
(214.8 mg/ml) whereas AH.FH.09 exhibits the lowest
amount (134.3 mg/ml of polyphenols). Concerning fla-
vonoid content, AH.FC.09 and AH.FEr.09 have similar
amounts - 25.5 and 26.9 mg/ml respectively - and AH.
FH.09 presents the lowest amount of flavonoids
(13.5 mg/ml).
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Figure 2 Effect of different concentrations of propolis fractions - AH.FC.09 (a) and AH.FEr.09 (b) - on HCT-15 cell proliferation. Controls
were treated with DMSO alone. Results are presented as percentage of proliferation. ** p < 0.01 vs control. *** p < 0.001 vs control.
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The effect of propolis fractions on the viability of HCT-
15 cells was assessed by the sulforhodamine B assay
(Figure 1). Cells were incubated for 24, 48 and 72 hours
with different concentrations of propolis fractions. All
propolis samples led to a decrease in cell biomass of
HCT-15 cells in a dose- and time-dependent manner,
with IC50 values ranging from 0.005 to 0.026 mg/ml
(Figure 1 and Table 2). AH.FC.09 appears to be the most
effective and AH.FH.09 the least effective in decreasing
cell viability (Figure 1). At low concentrations AH.FH.09
seems to increase cell biomass, mainly after 48 and
72 hours incubation (Figure 1a).0 10 20 30
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Figure 3 Effect of propolis on HCT-15 cell metabolism. HCT-15 cells we
(b,d). Controls were treated with DMSO alone. Results are presented as glu
0.015 mg/ml vs control; # p < 0.05, 0.025 mg/ml vs control; * p < 0.05 0.05 mEffect of propolis fractions on cell proliferation
To assess the effect of propolis on cell proliferation,
HCT-15 cells were treated with IC50 concentrations, as
well as two higher concentrations of the most effective
fractions, AH.FC.09 and AH.FEr.09.
Both fractions were able to decrease HCT-15 cell pro-
liferation (Figure 2). All tested concentrations of propolis
led to a decrease of approximately 40-60% in cell prolif-
eration after 24 hours of incubation.
Effect of propolis fractions on cell metabolism
After 24 hours of incubation with different concentra-
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g/ml vs control.
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metabolism of HCT-15 cells (Figure 3). AH.FC.09 led to
a decrease in glucose consumption and lactate production
along 24 hours of incubation (Figure 3a,c). AH.FEr.09 led
to a decrease in glucose consumption along 24 hours,
however, lactate production only decreased after 24 hours
of incubation with 0.05 mg/ml (Figure 3b,d).
Effect of propolis fractions on cell death
To evaluate the effect of propolis on cell death, HCT-15
cells were incubated with the IC50 values of each fraction
for 24 hours. AH.FC.09 and AH.FEr.09 fractions moder-
ately induced cell death on HCT-15 cells, about 7% and
5%, respectively (Figure 4).
Discussion
Propolis has been widely studied for its biological prop-
erties and has been used by several industries, such as
food, cosmetics and pharmaceutical industries [2,29]. InCo
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Figure 4 Effect of propolis on HCT-15 cell death. Representative dotplo
graphic representation (b). Cells were treated with IC50 concentrations for
presented as percentage of cell death. ** p < 0.01 vs control. *** p < 0.001vitro and in vivo studies on propolis antitumor activity
have been widely reported [13,18,30-35], however, there
is only one study exploring Portuguese propolis with this
purpose [13,18,30-35], where the authors reported inhib-
ition of human renal cancer cell growth.
In the present study, we aimed to assess the antitumor
activity of a fractionated Portuguese propolis sample col-
lected in Angra do Heroísmo, an island of the Azores
Archipelago, on HCT-15 colon cancer cell line. This is
the first study to assess antitumor activity in this tumor
model and with Portuguese propolis.
Our results showed that all propolis fractions were able
to decrease cell viability of colon tumor cells (Figure 1), be-
ing in accordance with previous reports [30,32-35]. How-
ever, lower concentrations of the hexane fraction seem to
increase the number of viable cells (Figure 1a). Propolis is
a mixture of several compounds from plants and since this
solvent has low polarity, the hexane fraction has lower
amounts of dissolved polyphenols and flavonoids thant of cell population distribution stained for Annexin V and PI (a) and
24 hours and control was treated with DMSO alone. Results are
vs control.
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the main bioactive compounds in European propolis. This
is probably why this fraction was not able to decrease cell
viability when tested at low concentration. The chloroform
fraction seems to be more powerful in decreasing cell via-
bility (Figure 1b), which may be due to the presence of su-
perior amounts of compounds of higher polarity, like the
phenolic compounds (Table 1), which are more efficiently
extracted with chloroform than hexane.
Since AH.FC.09 and AH.FEr.09 were the most effect-
ive fractions, we further assessed its effects on cell prolif-
eration, metabolism and death. The results show that
propolis led to a decrease in HCT-15 cell proliferation
(Figure 2), as described in other studies [33-35]. Regard-
ing the effect of propolis on cell death, there was a small
induction in cell death (Figure 4), again in accordance
with results of other reports concerning other propolis
samples [30,31]. Ishihara et al. [30] showed that Chinese
and Brazilian propolis induced apoptosis in cell cultures of
human colon carcinoma cells. Also, Szliszka et al. [31]
showed that tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL) in prostate cancer cells is mark-
edly augmented by a propolis ethanol extract from Poland.
The cytotoxic effect of the studied propolis fractions
may be related to the overall effect of their phenolic
compounds. Over the last decades, several phenolic com-
pounds (mainly flavonoids and phenolic acids) have been
linked to propolis antitumor activity against colorectal
tumor cells in vitro. Among flavonoids, quercetin is able to
inhibit cell growth with cytotoxic activity [36,37], to reduce
cell proliferation [38], induce cell cycle arrest and apoptosis
[37,39]. Apigenin, another flavonoid, can induce cell cycle
arrest and apoptosis [40,41]; rutin is able to inhibit cell pro-
liferation and induce apoptosis [42,43]; galangin shows
antiproliferative capacities [35] and chrysin is able to in-
hibit cell growth, reduce cell proliferation, induce cell
cycle arrest and apoptosis [35,42,43]. In what concerns
phenolic acids, cinnamic acid displayed antiproliferative
effects [35,44] and caffeic acid phenethyl ester (CAPE)
inhibited proliferation [35] and induced growth arrest
and apoptosis [45].
To the best of our knowledge, propolis effect on glyco-
lytic metabolism of cancer cells has not yet been investi-
gated. The present study shows for the first time that a
Portuguese propolis sample has antitumor activity on
HCT-15 colon cancer cell line and that such activity
likely involves disturbance of tumor cell metabolism, as
assessed by the effects on the rates of glucose consump-
tion and lactate production (Figure 3). It is known that
cancer cells have preference for glycolytic metabolism,
displaying higher glycolytic rates than those of normal
cells [46]. In normal cells and in the presence of oxygen,
pyruvate undergoes oxidative phosphorylation, leading
to highly efficient energy production in the form of ATP.However, if oxygen levels are low, pyruvate is converted
into lactate in the cytoplasm, a process much less efficient
in terms of energy production. In the case of tumor cells,
pyruvate is preferentially converted to lactate even in the
presence of oxygen, a process known as the Warburg
effect [46]. To maintain intracellular pH, and to avoid cell
death, tumor cells use beyond other pH regulators, mono-
carboxylate transporters (MCTs) for proton-coupled lac-
tate efflux and maintenance of glycolytic rates [47].
Therefore, if the activity of these transporters is inhibited,
there will be an increase of intracellular lactate and conse-
quent impairment of glycolysis, with a consequent de-
crease in glucose consumption [48].
Although propolis effect on glycolytic metabolism of
cancer cells has not yet been investigated, there are some
studies that associate a wide range of phenolic com-
pounds, some present in propolis samples, to glycolytic
metabolism inhibition. Shim et al. [22] showed that the
flavonoids naringenin, morin, silybin and quercetin are
competitive inhibitors of MCT1 in Caco-2 colon cancer
cells. Also, Wang et al. [23] showed that several flavo-
noids, such as apigenin, biochanin A, chrysin, diosemin,
fisetin, genistein, hesperitin, kaempferol, luteolin, morin,
narigenin, phloretin, and quercetin may significantly alter
the pharmacokinetics and pharmacodynamics of MCT1
substrates. Phenolic acids can also be responsible for
MCT inhibition. Alpha-cyano-4-hydroxycinnamic acid, a
cinnamic acid derivative, has been associated with MCT
activity inhibition in several tumor models [24-26]. How-
ever, further studies are needed to understand the mech-
anism by which propolis affects cell glycolytic metabolism,
namely if it is mediated by inhibition of lactate transport
through MCTs.
Conclusions
The cytotoxicity of the Portuguese propolis sample stud-
ied appears to be due not only to a decrease in cell prolif-
eration and induction of cell death but also to disturbance
of cancer cell glycolytic metabolism. Overall, these results
support that Portuguese propolis or its components
should be further explored as therapeutic agents in the
treatment of cancer.
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